Skip to main content
Premium Trial:

Request an Annual Quote

Prescient Medicine Acquires Pharmacogenomics Lab PGxL Laboratories

NEW YORK (GenomeWeb) – Prescient Medicine announced today that it has acquired Kentucky-based pharmacogenomics testing reference lab PGxL Laboratories.

Prescient offers toxicology, pharmacogenomic, and other testing, including a recently launched service called LifeKit Predict that predicts patients' risk for opioid addiction based on their genetic profiles. According to Prescient, the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers. The firm added that it expects to begin processing its tests at the PGxL facility by the end of the year.

Specific terms of the deal were not disclosed.

"The purchase of PGxL is an opportunity to better service the growing list of clinics, doctors, and patients who see the value in important clinical tools like LifeKit Predict," Prescient Founder and CEO Keri Donaldson said in a statement.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.